Zexian Zeng

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor cells and T cells.

Kumar S, Zeng Z, Bagati A, Tay RE, Sanz LA, Hartono SR, Ito Y, Abderazzaq F, Hatchi E, Jiang P, Cartwright ANR, Olawoyin O, Mathewson ND, Pyrdol JW, Li MZ, Doench JG, Booker MA, Tolstorukov MY, Elledge SJ, Chedin F, Liu XS, Wucherpfennig KW.

Cancer Discov. 2021 Mar 11. PMID: 33707234

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.

Gu SS, Zhang W, Wang X, Jiang P, Traugh N, Li Z, Meyer C, Stewig B, Xie Y, Bu X, Manos MP, Font-Tello A, Gjini E, Lako A, Lim K, Conway J, Tewari AK, Zeng Z, Sahu AD, Tokheim C, Weirather JL, Fu J, Zhang Y, Kroger B, Liang JH, Cejas P, Freeman GJ, Rodig S, Long HW, Gewurz BE, Hodi FS, Brown M, Liu XS.

Cancer Discov. 2021 Jun. 11(6):1524-1541. PMID: 33589424

Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network.

Zeng Z, Fu J, Cibulskis C, Jhaveri A, Gumbs C, Das B, Sanchez-Espiridion B, Janssens S, Taing L, Wang J, Lindsay J, Vilimas T, Zhang J, Tokheim C, Das Sahu A, Jiang P, Yan C, Duose DY, Cerami E, Chen L, Cohen D, Chen QR, Enos RA, Huang X, Lee JJ, Liu Y, Neuberg DS, Nguyen C, Patterson C, Sarkar S, Shukla SA, Tang M, Tsuji J, Uduman M, Wang X, Weirather JL, Yu J, Yu J, Zhang J, Zhang J, Meerzaman D, Thurin M, Futreal PA, Karlovich C, Gabriel SB, Wistuba II, Liu XS, Wu C.

Clin Cancer Res. 2020 Dec 15. PMID: 33323402

Clonal tracing reveals diverse patterns of response to immune checkpoint blockade.

Gu SS, Wang X, Hu X, Jiang P, Li Z, Traugh N, Bu X, Tang Q, Wang C, Zeng Z, Fu J, Meyer C, Zhang Y, Cejas P, Lim K, Wang J, Zhang W, Tokheim C, Sahu AD, Xing X, Kroger B, Ouyang Z, Long H, Freeman GJ, Brown M, Liu XS.

Genome Biol. 2020 10 15. 21(1):263. PMID: 33059736

Preoperative magnetic resonance imaging use and oncologic outcomes in premenopausal breast cancer patients.

Zeng Z, Amin A, Roy A, Pulliam NE, Karavites LC, Espino S, Helenowski I, Li X, Luo Y, Khan SA.

NPJ Breast Cancer. 2020. 6:49. PMID: 33083528

TIMER2.0 for analysis of tumor-infiltrating immune cells.

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS.

Nucleic Acids Res. 2020 07 02. 48(W1):W509-W514. PMID: 32442275

Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer.

Zeng Z, Vo A, Li X, Shidfar A, Saldana P, Blanco L, Xuei X, Luo Y, Khan SA, Clare SE.

NPJ Breast Cancer. 2020. 6:24. PMID: 32566745

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate.

Lee O, Sullivan ME, Xu Y, Rogers C, Muzzio M, Helenowski I, Shidfar A, Zeng Z, Singhal H, Jovanovic B, Hansen N, Bethke KP, Gann PH, Gradishar W, Kim JJ, Clare SE, Khan SA.

Clin Cancer Res. 2020 01 01. 26(1):25-34. PMID: 31570566

Rich Text Formatted EHR Narratives: A Hidden and Ignored Trove.

Zeng Z, Zhao Y, Sun M, Vo AH, Starren J, Luo Y.

Stud Health Technol Inform. 2019 Aug 21. 264:472-476. PMID: 31437968

Cancer classification and pathway discovery using non-negative matrix factorization.

Zeng Z, Vo AH, Mao C, Clare SE, Khan SA, Luo Y.

J Biomed Inform. 2019 08. 96:103247. PMID: 31271844